Eli Lilly (NYSE:LLY) announced today that it committed an additional $4.5 billion investment across certain Indiana manufacturing sites. The company’s commitment extends to two of its three locations in Lebanon, Indiana. It brings its total Indiana capital expansion commitments since 2020 to more than $21 billion. This marks the latest investment across the U.S., with…

Thermo Fisher Scientific today announced the introduction of the Gibco CTS DynaXS single-use bioreactor for cell therapy manufacturing. Waltham, Massachusetts-based Thermo Fisher designed the expansion platform to help cell therapy developers scale manufacturing with control, flexibility and regulatory readiness. Thermo Fisher said its stirred-tank, single-use system supports cell expansion across development and early clinical volumes.…

AstraZeneca has officially opened its new active pharmaceutical ingredient (API) manufacturing facility in Dublin, Ireland. IDA Ireland, the foreign direct investment arm of the Irish government, said in a news release that the new facility brings advanced automation, AI and innovative new technologies into one place to continue to innovate in science and manufacturing. “Healthcare…

Novartis announced today that it plans to add a new active pharmaceutical ingredient (API) manufacturing plant in North Carolina. The company expects the facility in Morrisville to focus on APIs for solid dosage tablets, capsules and RNA therapeutics. Novartis said its new facility marks a critical step to strengthen end-to-end U.S. production capability. It comes…

West Pharmaceutical Services (NYSE:WST) announced today that it launched its NovaPure 0.5 mL plunger for ISO glass syringes. Exton, Pennsylvania-based West designed the syringes to meet the performance and quality requirements for ophthalmic drug applications. The plunger is West’s newest ready-to-use elastomer component within the NovaPure portfolio. This includes the existing 1 mL and 1-3…

PCI Pharma Services announced that it made a series of infrastructure investments to deepen its sterile fill-finish and advanced drug delivery capabilities. Philadelphia-based PCI says its latest investments come as part of a broader commitment exceeding $1 billion. Its investment spans across its U.S. and European operations. The company hopes to provide seamless support for…

BD (NYSE:BDX) announced today that it entered into a strategic, non-exclusive collaboration with Suttons Creek, a BlueRidge Life Sciences company. The companies aim to help pharmaceutical and biotech companies more efficiently navigate the engineering, testing, quality and regulatory complexity associated with combination product development. Under the collaboration, ZebraSci, BD’s device-agnostic combination product testing organization, is…

Shibuya Corp. is showcasing its Cell Processing Isolator CPi, an isolator-based system designed to support aseptic cell culture and processing for regenerative medicine and cell therapy manufacturing. The CPi system is intended to provide Grade A/ISO 5 particulate air quality environments within a broader cell processing center. Shibuya says the system helps manufacturers reduce direct…

AbbVie (NYSE:ABBV) today announced a $1.4 billion investment to build a new pharmaceutical manufacturing campus in Durham, North Carolina. The 185-acre, state-of-the-art campus will integrate advanced manufacturing and laboratory technologies with AI to support the production of AbbVie’s immunology, neuroscience and oncology medicine. It marks the latest significant investment in pharmaceutical manufacturing after the company…

Amerikooler, a U.S. manufacturer of commercial refrigeration equipment, is highlighting its walk-in door portfolio and the selection criteria that determine which door belongs in which application. Door choice drives three measurable outcomes: energy loss through the opening, throughput for workers and equipment moving through it, and how long the door lasts before the gasket, hinges…